Molecular and cellular effects of in vitro shockwave treatment on lymphatic endothelial cells

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Rohringer, Sabrina ^a,b   Holnthoner, Wolfgang ^a,b   Hackl, Matthias ^b,d   Weihs, Anna M ^b,c   Rünzler, Dominik ^b,c   Skalicky, Susanna ^b,d   Karbiener, Michael ^e   Scheideler, Marcel ^e   Pröll, Johannes ^b,f   Gabriel, Christian ^b,f   Schweighofer, Bernhard ^g   Gröger, Marion ^g,h   Spittler, Andreas ^b,h   Grillari, Johannes ^b,i   Redl, Heinz ^a,b  

^a LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

^b Austrian Cluster for Tissue Regeneration   (Austria)

^c UNIVERSITY OF APPLIED SCIENCES TECHNIKUM WIEN   (Austria)

^d TAmiRNA GmbH   (Austria)

^e GRAZ UNIVERSITY OF TECHNOLOGY   (Austria)

^f Red Cross Blood Transfusion Center   (Austria)

^g Universitatsklinik fur Dermatologie   (Austria)

^h MEDICAL UNIVERSITY OF VIENNA   (Austria)

ⁱ UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; PODOPLANIN; TRANSCRIPTOME;

ANGIOGENESIS; ARTICLE; CELL ADHESION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL SUBPOPULATION; CONTROLLED STUDY; EXTRACORPOREAL LITHOTRIPSY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO SHOCKWAVE TREATMENT; IN VIVO STUDY; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOGENESIS; MOLECULAR MECHANICS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SHOCK WAVE LITHOTRIPTER; UMBILICAL VEIN ENDOTHELIAL CELL; BIOSYNTHESIS; CELL MOTION; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; HIGH-ENERGY SHOCK WAVE; LYMPH NODE METASTASIS; LYMPH VESSEL; PATHOLOGY; RADIATION RESPONSE; SIGNAL TRANSDUCTION; WOUND HEALING;

CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HIGH-ENERGY SHOCK WAVES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MICRORNAS; SIGNAL TRANSDUCTION; TRANSCRIPTOME; WOUND HEALING;

EID: 84917710579     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114806     Document Type: Article

References (51)

1. Nomi M, Atala A, Coppi PD, Soker S (2002) Principals of neovascularization for tissue engineering. Molecular Aspects of Medicine 23(6): 463-483.
2. Mikos AG, Sarakinos G, Leite SM, Vacant JP, Langer R (1993) Laminated three-dimensional biodegradable foams for use in tissue engineering. Biomaterials 14(5): 323-330.
3. Soker S, Machado M, Atala A (2000) Systems for therapeutic angiogenesis in tissue engineering. World Journal of Urology 18(1): 10-18.
4. Gerdesmeyer L, Wagenpfeil S, Haake M, Maier M, Loew M, et al. (2003) Extracorporeal shock wave therapy for the treatment of chronic calcifying tendonitis of the rotator cuff: a randomized controlled trial. JAMA 290(19): 2573-2580.
5. Haupt G (1997) Use of extracorporeal shock waves in the treatment of pseudarthrosis, tendinopathy and other orthopedic diseases. The Journal of Urology 158(1): 4-11.
6. Wang CJ, Wang FS, Yang KD, Weng LH, Ko JY (2006) Long-term results of extracorporeal shockwave treatment for plantar fasciitis. The American journal of sports medicine 34(4): 592-596.
7. Kuo YR, Wang CT, Wang FS, Chiang YC, Wang CJ (2009) Extracorporeal shock-wave therapy enhanced wound healing via increasing topical blood perfusion and tissue regeneration in a rat model of STZ-induced diabetes. Wound Repair and Regeneration 17(4): 522-530.
8. Mittermayr R, Antonic V, Hartinger J, Kaufmann H, Redl H, et al. (2012) Extracorporeal shock wave therapy (ESWT) for wound healing: technology, mechanisms, and clinical efficacy. Wound Repair and Regeneration 20(4): 456-465.
9. Wang CJ, Kuo YR, Wu RW, Liu RT, Hsu CS, et al. (2009) Extracorporeal shockwave treatment for chronic diabetic foot ulcers. Journal of Surgical Research 152(1): 96-103.
10. Schaden W, Thiele R, Kölpl C, Pusch M, Nissan A, et al. (2007) Shock wave therapy for acute and chronic soft tissue wounds: a feasibility study. Journal of Surgical Research 143(1): 1-12.
11. Jaalouk DE, Lammerding J (2009) Mechanotransduction gone awry. Nature Reviews Molecular Cell Biology 10(1): 63-73.
12. Zins SR, Amare MF, Tadaki DK, Elster EA, Davis TA (2010) Comparative analysis of angiogenic gene expression in normal and impaired wound healing in diabetic mice: effects of extracorporeal shock wave therapy. Angiogenesis 13(4): 293-304.
13. Yip HK, Chang LT, Sun CK, Youssef AA, Sheu JJ, et al. (2008) Shock wave therapy applied to rat bone marrow-derived mononuclear cells enhances formation of cells stained positive for CD31 and vascular endothelial growth factor. Circulation journal: Official Journal of the Japanese Circulation Society 72(1): 150-156.
14. Serizawa F, Ito K, Matsubara M, Sato A, Shimokawa H, et al. (2011) Extracorporeal shock wave therapy induces therapeutic lymphangiogenesis in a rat model of secondary lymphoedema. European Journal of Vascular and Endovascular Surgery 42(2): 254-260.
15. Kubo M, Li TS, Kamota T, Ohshima M, Shirasawa B, et al. (2010) Extracorporeal shock wave therapy ameliorates secondary lymphedema by promoting lymphangiogenesis. Journal of Vascular Surgery 52(2): 429-434.
16. Holfeld J, Tepeköylü C, Kozaryn R, Urbschat A, Zacharowski K, et al. (2014) Shockwave therapy differentially stimulates endothelial cells: implications on the control of inflammation via Toll-like receptor 3. Inflammation 37(1): 65-70.
17. Chen YJ, Kuo YR, Yang KD, Wang CJ, Sheen Chen SM, et al. (2004) Activation of extracellular signal-regulated kinase (ERK) and p38 kinase in shock wave-promoted bone formation of segmental defect in rats. Bone 34(3): 466-477.
18. Weihs AM, Fuchs C, Teuschl AH, Hartinger J, Slezak P, et al. (2014) Shockwave treatment enhances cell proliferation and improves wound healing by ATP release coupled extracellular signal-regulated kinase (ERK) activation. Journal of Biological Chemistry, jbc-M114. doi: 10.1074/jbc.M114.580936.
19. Marin T, Gongol B, Chen Z, Woo B, Subramaniam S, et al. (2013) Mechanosensitive microRNAs - role in endothelial responses to shear stress and redox state. Free Radical Biology and Medicine 64: 61-68.
20. Kriehuber E, Breiteneder-Geleff S, Groeger M, Soleiman A, Schoppmann SF, et al. (2001) Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. The Journal of Experimental Medicine 194(6): 797-808.
21. Gröger M, Niederleithner H, Kerjaschki D, Petzelbauer P (2007) A previously unknown dermal blood vessel phenotype in skin inflammation. Journal of Investigative Dermatology 127(12): 2893-2900.
22. Petzelbauer P, Bender JR, Wilson J, Pober JS (1993) Heterogeneity of dermal microvascular endothelial cell antigen expression and cytokine responsiveness in situ and in cell culture. The Journal of Immunology 151(9): 5062-5072.
23. Wolbank S, Peterbauer A, Fahrner M, Hennerbichler S, Van Griensven M, et al. (2007) Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue. Tissue engineering 13(6): 1173-1183.
24. Holfeld J, Tepeköylü C, Kozaryn R, Mathes W, Grimm M, et al. (2014) Shock Wave Application to Cell Cultures. Journal of Visualized Experiments 86: e51076-e51076.
25. Holnthoner W, Hohenegger K, Husa AM, Muehleder S, Meinl A, et al. (2012) Adipose-derived stem cells induce vascular tube formation of outgrowth endothelial cells in a fibrin matrix. Journal of Tissue Engineering and Regenerative Medicine doi: 10.1002/term.1620.
26. Rohringer S, Hofbauer P, Schneider KH, Husa AM, Feichtinger G, et al. (2014) Mechanisms of vasculogenesis in 3D fibrin matrices mediated by the interaction of adipose-derived stem cells and endothelial cells. Angiogenesis 1-13: doi 10.1007/s10456-014-9439-0.
27. Dellago H, Preschitz-Kammerhofer B, Terlecki-Zaniewicz L, Schreiner C, Fortschegger K, et al. (2013) High levels of oncomiR-21 contribute to the senescence-induced growth arrest in normal human cells and its knock-down increases the replicative lifespan. Aging Cell 12(3): 446-458.
28. Smyth GK (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Statistical Applications in Genetics and Molecular Biology 3(1): doi:10.2202/1544-6115.1027.
29. Dweep H, Sticht C, Pandey P, Gretz N (2011) miRWalk-database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. Journal of Biomedical Informatics 44(5): 839-847.
30. Mittermayr R, Hartinger J, Antonic V, Meinl A, Pfeifer S, et al. (2011) Extracorporeal shock wave therapy (ESWT) minimizes ischemic tissue necrosis irrespective of application time and promotes tissue revascularization by stimulating angiogenesis. Annals of Surgery 253(5): 1024-1032.
31. Nishida T, Shimokawa H, Oi K, Tatewaki H, Uwatoku T, et al. (2004) Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo. Circulation 110(19): 3055-3061.
32. Cortez MA, Nicoloso MS, Shimizu M, Rossi S, Gopisetty G, et al. (2010) miR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma. Genes, Chromosomes and Cancer 49(11): 981-990.
33. Kuo YR, Wang CT, Wang FS, Yang KD, Chiang YC, et al. (2009) Extracorporeal shock wave treatment modulates skin fibroblast recruitment and leukocyte infiltration for enhancing extended skin-flap survival. Wound Repair and Regeneration 17(1): 80-87.
34. Mäkinen T, Norrmen C, Petrova TV (2007) Molecular mechanisms of lymphatic vascular development. Cellular and Molecular Life Sciences 64(15): 1915-1929.
35. Davis TA, Stojadinovic A, Anam K, Amare M, Naik S, et al. (2009) Extracorporeal shock wave therapy suppresses the early proinflammatory immune response to a severe cutaneous burn injury. International Wound Journal 6(1): 11-21.
36. Schacht V, Dadras SS, Johnson LA, Jackson DG, Hong YK, et al. (2005) Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. The American Journal of Pathology 166(3): 913-921.
37. Schacht V, Ramirez MI, Hong YK, Hirakawa S, Feng D, et al. (2003) T1α/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. The EMBO Journal 22(14): 3546-3556.
38. Gröger M, Loewe R, Holnthoner W, Embacher R, Pillinger M, et al. (2004) IL-3 induces expression of lymphatic markers Prox-1 and podoplanin in human endothelial cells. The Journal of Immunology 173(12): 7161-7169.
39. Cheng M, Guan X, Li H, Cui X, Zhang X, et al. (2013) Shear stress regulates late EPC differentiation via mechanosensitive molecule-mediated cytoskeletal rearrangement. PloS One 8(7): e67675.
40. Klein U, Lia M, Crespo M, Siegel R, Shen Q, et al. (2010) The DLEU2/miR-15a/16-1 Cluster Controls B Cell Proliferation and Its Deletion Leads to Chronic Lymphocytic Leukemia. Cancer Cell 17(1): 28-40.
41. Jasielska M, Semkova I, Shi X, Schmidt K, Karagiannis D, et al. (2010) Differential role of tumor necrosis factor (TNF)-α receptors in the development of choroidal neovascularization. Investigative Ophthalmology & Visual Science 51(8): 3874-3883.
42. Verma K, Tran D, Bryan BA, Mitchell DC (2013) Meta-analysis of Infantile Hemangioma Endothelial Cell Microarray Expression Data Reveals Significant Aberrations of Gene Networks Involved in Cell Adhesion and Extracellular Matrix Composition. Angiology 1(107): 2.
43. Nagahara A, Nakayama M, Oka D, Tsuchiya M, Kawashima A, et al. (2010) SERPINE2 is a possible candidate promotor for lymph node metastasis in testicular cancer. Biochemical and Biophysical Research Communications 391(4): 1641-1646.
44. Primo L, di Blasio L, Roca C, Droetto S, Piva R, et al. (2007) Essential role of PDK1 in regulating endothelial cell migration. The Journal of Cell Biology 176(7): 1035-1047.
45. Teruyama K, Abe M, Nakano T, Takahashi S, Yamada S, et al. (2001) Neurophilin-1 is a downstream target of transcription factor Ets-1 in human umbilical vein endothelial cells. FEBS Letters 504(1): 1-4.
46. Rosette C, Roth RB, Oeth P, Braun A, Kammerer S, et al. (2005) Role of ICAM1 in invasion of human breast cancer cells. Carcinogenesis 26(5): 943-950.
47. Wick N, Haluza D, Gurnhofer E, Raab I, Kasimir MT, et al. (2008) Lymphatic Precollectors Contain a Novel, Specialized Subpopulation of Podoplanin low, CCL27-Expressing Lymphatic Endothelial Cells. The American Journal of Pathology 173(4): 1202-1209.
48. Nisato RE, Harrison JA, Buser R, Orci L, Rinsch C, et al. (2004) Generation and Characterization of Telomerase-Transfected Human Lymphatic Endothelial Cells with an Extended Life Span. The American Journal of Pathology 165(1): 11-24
49. Chang MWF, Grillari J, Mayrhofer C, Fortschegger K, Allmaier G, et al. (2005) Comparison of early passage, senescent and hTERT immortalized endothelial cells. Experimental Cell Research 309(1): 121-136
50. Schoppmann SF, Soleiman A, Kalt R, Okubo Y, Benisch C, et al. (2004) Telomerase-Immortalized Lymphatic and Blood Vessel Endothelial Cells are Functionally Stable and Retain Their Lineage Specificity. Microcirculation 11(3): 261-269
51. Hofbauer P, Riedl S, Witzeneder K, Hildner F, Wolbank S, et al. (2014) Human platelet lysate is a feasible candidate to replace fetal calf serum as medium supplement for blood vascular and lymphatic endothelial cells. Cytotherapy 16(9): 1238-1244.